ViQi
Excedr clients get $5,000 off a proof-of-concept study for optimized assay development using AI and imaging tools.
Cloud-Based Image Analysis Software to Accelerate Discovery
ViQi partners with life sciences teams to modernize assay development using custom AI and imaging workflows. Their scientists work directly with your lab to design and deploy image-based assays that reduce variability, improve reproducibility, and accelerate turnaround times, without changing your core biology.
ViQi offers a low-lift, $5K-off proof-of-concept study designed to demonstrate value in just 4 to 6 weeks. Whether you're optimizing viral titration, inactivation, neutralization, or clearance workflows, or seeking better insight into off-target effects, our software platform integrates seamlessly with your existing assays and infrastructure. No new hardware required. Just smarter, faster assays that are ready for scale.
Excedr clients can take advantage of this proof-of-concept study—built to help teams accelerate assay development using AI and imaging, without disrupting existing workflows.
Custom Assays, Guided by Scientists – Powered by AI.
ViQi partners with biotech and pharma teams to deliver AI-driven imaging solutions that go beyond today's challenges.
Their cross-disciplinary scientists design custom assays that seamlessly integrate into existing workflows, accelerate data insights, and support critical regulatory compliance across development pipelines.
"We have collaborated with the ViQi team across multiple companies, and their dedication to developing a highly customized pipeline for our analyses has been exceptional. Their expertise and unwavering commitment to quality consistently exceed expectations, delivering results that accelerate algorithm development for miltiplex immunofluorescence digital pathology workflows."
Jiyun Byun
Senior Director, Vision and Machine Learning, Akoya Biosciences
